Long-Term Outcome and Role of Biology within Risk-Adapted Treatment Strategies: The Austrian Neuroblastoma Trial A-NB94.
Fiedler S, Ambros IM, Glogova E, Benesch M, Urban C, Mayer M, Ebetsberger-Dachs G, Bardi E, Jones N, Gamper A, Meister B, Crazzolara R, Amann G, Dieckmann K, Horcher E, Kerbl R, Brunner-Herglotz B, Ziegler A, Ambros PF, Ladenstein R.
Fiedler S, et al. Among authors: gamper a.
Cancers (Basel). 2021 Feb 2;13(3):572. doi: 10.3390/cancers13030572.
Cancers (Basel). 2021.
PMID: 33540616
Free PMC article.